Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, according ...
Mar 28, 2013
0
0
Human immunodeficiency virus (HIV) disease represents a global health problem concern in the world especially in many areas of Africa. According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), there were 24.7 ...
Jan 13, 2015
0
6
UVA Health researchers have identified a potential treatment to prevent severe COVID-19 in patients at great risk.
Mar 13, 2023
0
35
Harmful side effects from a common chemotherapy drug could be the result of a single mutation, according to a study published in Cell Stem Cell.
Sep 27, 2021
0
68
Nearly two decades ago, a gene therapy restored vision to Lancelot, a Briard dog who was born with a blinding disease. This ushered in a period of hope and progress for the field of gene therapy aimed at curing blindness, ...
Sep 10, 2019
0
8
In a preclinical breakthrough that could transform cell therapies for incurable diseases, researchers at Sinai Health and the University of Toronto have developed a technology that may one day eliminate the need for immunosuppressive ...
Nov 29, 2023
0
38
To impact and improve patient care, the study of artificial intelligence (AI) tools to support screening mammography must now shift from simulated research trials to robust clinical evaluations, according to Constance Lehman, ...
Aug 13, 2020
0
20
For the first time, a highly transmissible strain of the antibiotic-resistant superbug MRSA currently plaguing hospitals in Northern Europe has been isolated from hedgehogs in Helsinki. The study by Venla Johansson and colleagues ...
Apr 22, 2022
0
22
Researchers at the University of Illinois Chicago have published a study showing a promising approach to using drug repurposing to treat genetic diseases.
Dec 17, 2020
1
87
Investigators from Cedars-Sinai Cancer have identified an investigational therapeutic approach that could be effective against treatment-resistant prostate cancer. Results of their Phase II clinical trial, published in Molecular ...
Nov 2, 2022
0
73
